Mexico Veterinary Ocular Medicine Market by Route of Administration (2024–2032)

Strong clinical preference for topical therapies was defined in the veterinary ocular segment, with 2024 was valued at USD 47,976.72 thousand, significantly ahead of oral (USD 19,869.39 thousand) and injectable routes (USD 11,441.15 thousand). Topical administration is projected to dominate in 2025 at USD 50,193.88 thousand, whereas oral and injectable routes remain lower at USD 20,659.16 thousand and USD 11,825.50 thousand, respectively. This trend underscores veterinarians’ focus on targeted ocular treatment, maximizing therapeutic efficacy while minimizing systemic exposure. Among the routes, topical products consistently lead, reflecting their convenience, precise dosing, and rapid onset of action, while injectables record the lowest share due to higher complexity, administration challenges, and cost.

Sustained expansion is projected for the Mexico Veterinary Ocular Medicine Market by Administration Route through 2032. Topical formulations are expected to reach at USD 75,646.40 thousand, far outpacing oral (USD 29,812.98 thousand) and injectable (USD 16,303.42 thousand) segments. The dominance of topical products is driven by clinical effectiveness, ease of application, cost-efficiency, enhanced patient compliance, minimal systemic side effects, and growing veterinary preference for non-invasive treatment, making them the preferred route for ocular care.